The Effect of Steroids on Endolymphatic Hydrops Induced by an Immunological Technique

  • Yoshiro Yazawa
  • Masaaki Kitahara
  • Kaoru Uchida
  • Izumi Sawada


Steroids are less frequently used for the treatment of Ménière’s disease compared with their use for sudden deafness or facial paresis. Hauser [1] reported 2 cases of Ménière’s disease in which hearing was improved by the administration of steroids. McCabe [2], Hughes et al. [3, 4] and Shea [5] also reported the efficacy of steroids in cases of sensorineural hearing loss and/or Ménière’s disease with a suspected immunological origin. According to our 1970 and 1980 nationwide surveys [6, 7], incidences where otolaryngologists treated Ménière’s disease with steroids increased from 2% to 7%. It is true that steroids are one of the few drugs which have promising effects on certain types of Ménière’s disease. This study was made to examine the effects of steroids on endolymphatic hydrops experimentally induced in guinea pigs by an immunological technique [8].


Sensorineural Hearing Loss Endolymphatic Hydrops Facial Paresis Local Immunization Sudden Deafness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hauser E (1959) Ménière’s disease; a new therapeutic approach. J Am Geriatr Soc 7: 874–876Google Scholar
  2. 2.
    McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88: 585–589PubMedGoogle Scholar
  3. 3.
    Hughes GB, Kinney SE, Barna BP, Calabrese LH (1983) Autoimmune reactivity in Ménière’s disease. A preliminary report. Laryngoscope 93: 410–417Google Scholar
  4. 4.
    Hughes GB, Barna BP, Kinney SE, Calabrese LH, Hamid MA, Nalepa NJ (1988) Autoimmune endolymphatic hydrops: five-year review. Otolaryngol Head Neck Surg 88: 221–225Google Scholar
  5. 5.
    Shea JJ (1983) Autoimmune sensorineural hearing loss as aggravating factor in Ménière’s disease. Adv Otorhinolaryngol 30: 254–257PubMedGoogle Scholar
  6. 6.
    Yagi N, Kitahara M (1972) Treatment for Ménière’s disease (in Japanese). Pract Otol (Kyoto) 65: 923–930Google Scholar
  7. 7.
    Kitajima K, Saito H, Kitano H, Kitahara M (1981) The trend of treatment in Ménière’s disease during the past 10 years (in Japanese). Pract Otol (Kyoto) 74: 2396–2405Google Scholar
  8. 8.
    Sawada I, Kitahara M, Kitajima K, Yazawa Y (1987) Induction of experimental endolymphatic hydrops by immunologic technique. Am J Otol 8: 330–334PubMedGoogle Scholar
  9. 9.
    Paparella MM, Goycoolea MV, Meyerhoff WL, Shea D (1979) Endolymphatic hydrops and otitis media. Laryngoscope 89: 43–54PubMedGoogle Scholar
  10. 10.
    Kimura RS, Schuknecht HF (1965) Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Oto-rhino-larying 27: 343–354Google Scholar
  11. 11.
    Kimura RS (1985) Surgical and drug intervention in experimentally induced endolymphatic hydrops. In: Nomura Y (ed) Hearing and dizziness. Igaku-Shoin, Tokyo, p 16Google Scholar
  12. 12.
    Matsubara H (1981) Basic experiment of attacks of Ménière’s disease (in Japanese). Pract Otol (Kyoto) 74: 2418–2449Google Scholar
  13. 13.
    Kawase T, Kusakari J, Shinkawa H, Takasaka T (1988) Effect of perilymphatic pressure on the CM threshold in hydropic ears of guinea pigs (in Japanese). Equilibrium Res [Suppl] 4: 37–40CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1990

Authors and Affiliations

  • Yoshiro Yazawa
  • Masaaki Kitahara
  • Kaoru Uchida
  • Izumi Sawada

There are no affiliations available

Personalised recommendations